全文获取类型
收费全文 | 128214篇 |
免费 | 12888篇 |
国内免费 | 9605篇 |
专业分类
耳鼻咽喉 | 1040篇 |
儿科学 | 1350篇 |
妇产科学 | 1235篇 |
基础医学 | 13392篇 |
口腔科学 | 2382篇 |
临床医学 | 17867篇 |
内科学 | 17105篇 |
皮肤病学 | 1073篇 |
神经病学 | 6563篇 |
特种医学 | 4543篇 |
外国民族医学 | 59篇 |
外科学 | 11885篇 |
综合类 | 25038篇 |
现状与发展 | 32篇 |
一般理论 | 14篇 |
预防医学 | 10319篇 |
眼科学 | 3533篇 |
药学 | 13681篇 |
147篇 | |
中国医学 | 9325篇 |
肿瘤学 | 10124篇 |
出版年
2024年 | 448篇 |
2023年 | 1913篇 |
2022年 | 5335篇 |
2021年 | 6670篇 |
2020年 | 5288篇 |
2019年 | 4134篇 |
2018年 | 4401篇 |
2017年 | 4032篇 |
2016年 | 3797篇 |
2015年 | 5952篇 |
2014年 | 7523篇 |
2013年 | 7070篇 |
2012年 | 10258篇 |
2011年 | 11562篇 |
2010年 | 7880篇 |
2009年 | 6190篇 |
2008年 | 7312篇 |
2007年 | 6964篇 |
2006年 | 6690篇 |
2005年 | 6262篇 |
2004年 | 4079篇 |
2003年 | 4116篇 |
2002年 | 3580篇 |
2001年 | 3019篇 |
2000年 | 2689篇 |
1999年 | 2591篇 |
1998年 | 1660篇 |
1997年 | 1576篇 |
1996年 | 1276篇 |
1995年 | 1170篇 |
1994年 | 982篇 |
1993年 | 601篇 |
1992年 | 670篇 |
1991年 | 575篇 |
1990年 | 515篇 |
1989年 | 459篇 |
1988年 | 390篇 |
1987年 | 327篇 |
1986年 | 262篇 |
1985年 | 203篇 |
1984年 | 87篇 |
1983年 | 56篇 |
1982年 | 47篇 |
1981年 | 41篇 |
1980年 | 28篇 |
1979年 | 23篇 |
1977年 | 2篇 |
1964年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 109 毫秒
51.
The inferior alveolar nerve and facial nerve are the two most important nerves in the dental and maxillofacial region. The injury to them is one of the major postoperative complications after alveolar surgery and orthognathic surgery. However, recovering the nerve function after injury takes a long time and the recovery effect tends to be unsatisfactory. In recent years, an intensively investigated technique, low level laser which has been applying in assisting the recovery of nerve function, has been gradually proved to be effective in clinically treating postoperative nerve injury. In this article we review in terms of the mechanisms involved in low level laser-assisted functional restoration of nerve injury and its clinical application in the recovery of nerve function in the dental and maxillofacial area as well. 相似文献
52.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
53.
54.
Yaobin Ouyang Gongmeizi Liu Wenting Xu Zhen Yang Nianshuang Li Chuan Xie Chun Zhou Jiang Chen Yin Zhu Junbo Hong Nonghua Lu 《Oncology Letters》2021,21(2)
Helicobacter pylori (H. pylori) is a main risk factor for gastric cancer (GC). Epithelial-mesenchymal transition (EMT) is involved in the development and progression of H. pylori-associated GC. However, the exact molecular mechanism of this process remains unclear. The AKT/GSK3β signaling pathway has been demonstrated to promote EMT in several types of cancer. The present study investigated whether H. pylori infection induced EMT, and promoted the development and metastasis of cancer in the normal gastric mucosa, and whether this process was dependent on AKT activation. The expression levels of the EMT-associated proteins, including E-cadherin and N-cadherin, were determined in 165 gastric mucosal samples of different disease stages by immunohistochemical analysis. The expression levels of E-cadherin, N-cadherin, AKT, phosphorylated (p-)AKT (Ser473), GSK3β and p-GSK3β (Ser9) were further determined in H. pylori-infected Mongolian gerbil gastric tissues and cells co-cultured with H. pylori by immunohistochemical analysis and western blotting. The results indicated that the expression levels of the epithelial marker E-cadherin were decreased, whereas the expression levels of the mesenchymal marker N-cadherin were increased during gastric carcinogenesis. Their expression levels were associated with H. pylori infection. Furthermore, H. pylori infection resulted in downregulation of E-cadherin expression and upregulation of N-cadherin expression in Mongolian gerbils and GES-1 cells. In addition, an investigation of the associated mechanism of action revealed that p-AKT (Ser473) and p-GSK3β (Ser9) were activated in GES-1 cells following co-culture with H. pylori. Furthermore, following pretreatment of the cells with the AKT inhibitor VIII, the expression levels of E-cadherin, N-cadherin, p-AKT and p-GSK3β did not show significant differences between GES-1 cells that were co-cultured with or without H. pylori. The levels of p-AKT and p-GSK3β were increased in H. pylori-infected Mongolian gerbils. In conclusion, the present study demonstrated that H. pylori infection activated AKT and resulted in the phosphorylation and inactivation of GSK3β, which in turn promoted early stage EMT. These effects were AKT-dependent. This mechanism may serve as a prerequisite for GC development. 相似文献
55.
56.
肠易激综合征(Irritable bowel syndrome,IBS)是临床常见病、多发病,其治疗方法丰富,但部分患者疗效欠佳,发展成难治性IBS。目前国内外关于针灸治疗难治性IBS的临床随机对照试验尚不多见。本文立足试验方案设计的“PICOS”原则,从研究对象及诊断标准、干预措施、对照措施、结局指标四个方面入手,重点探讨针刺辅助治疗难治性肠易激综合征临床试验设计的关键要点。从选择特色优势病种、明确诊断标准、制定符合临床实际的干预方案、运用符合目标的安慰针刺、结合研究设计和目的选定结局指标几个角度,阐述试验相关环节设计的原因和思考。 相似文献
57.
目的探讨关节镜下使用TightRope治疗后交叉韧带(PCL)撕脱骨折的技术应用和临床疗效。方法 12例膝关节PCL撕脱骨折患者在关节镜下使用TightRope固定PCL撕脱骨块。术后1周开始在支具保护下被动活动膝关节,术后10个月评估膝关节功能恢复情况。结果 12例患者均获随访,时间10~14个月,平均12.6个月,骨折均Ⅰ期愈合。1例屈膝受限15°,无伸膝受限;2例后抽屉试验(+)。Lysholm膝关节功能评分术前(45.6±6.3)分,术后10个月(87.8±4.8)分,差异有统计学意义(P 0.05)。结论关节镜下使用TightRope治疗PCL撕脱骨折固定可靠,操作相对简单,疗效满意。 相似文献
58.
Introduction: Cutaneous T-cell lymphomas (CTCL) are rare non-Hodgkin lymphomas of skin-homing T-cells that initially or mainly manifest cutaneously. Treatment of CTCL is challenging given the disease states’ varying presentation and prognosis. Systemic treatment options often lack comparative evidence and have relatively low response rates and short duration of response. The recent Food and Drug Administration (FDA) approval of mogamulizumab in adult patients with relapsed or refractory (R/R) CTCL after at least one prior line of therapy provided a new treatment option to patients with advanced disease.
Areas covered: The authors discuss basic information about CTCL and mogamulizumab’s mechanism of action. Then, the authors discuss the agent’s efficacy. Finally, the authors evaluate the safety of mogamulizumab in comparison to other agents available in CTCL.
Expert opinion: Mogamulizumab has been shown to be an effective and well tolerated therapy for patients with relapsed and refractory MF/SS with excellent activity in the circulating component of the disease. 相似文献
59.
文题释义:跑:跑是双脚交替接触地面的周期性运动,但跑有一个双脚都离开地面的腾空期。幼儿在 1 岁多开始学习跑步,最初是走跑结合的移动方式,由于身体发育不完善,下肢力量弱,平衡能力差,容易摔倒;到 2.5岁,幼儿跑步的腾空阶段明显;到 6岁,早期跑步的特点基本消失。
着地方式:指的是人体在跑步着地阶段足部接触地面的方式,一般分为3种方式:分别为足跟着地(fore foot strike),跟骨先接触地面;全足着地(mid foot strike),全脚掌着地,即足跟与前足同时接触地面;前足着地(rear foot
strike):前足部首先接触地面。
背景:成年人跑步着地方式一直是国内外学者研究的重点,而幼儿跑步的着地方式也是不容忽视的内容。
目的:运用生物力学方法探究幼儿在跑步过程中,不同着地方式下的运动学和动力学指标的差异,为幼儿正确的跑步着地方式提供科学依据。
方法:在北京市海淀区某公立幼儿园中随机抽取幼儿74名,按年龄分为3岁组、4岁组、5岁组,采用BTS红外动作捕捉系统、Kistler三维测力台和VIXTA录像解析系统同步采集幼儿跑步过程中不同着地方式下的运动学、动力学数据;运用Anybody
5.2仿真建模软件计算下肢肌肉力量指标。试验前向受试者父母详细解释并签署知情同意书,试验方案符合北京师范大学的相关伦理要求。
结果与结论:①3岁组全足着地的比例最高,足跟着地的比例最低,5岁组全足着地的比例最低,足跟着地的比例最高;前足着地者的蹬伸时间大于足跟着地(P < 0.01)和全足着地(P < 0.05);②着地时刻,踝屈曲角度足跟着地者大于前足着地(P < 0.01)和全足着地者(P < 0.05),全足着地者大于前足着地(P < 0.05);前足着地者髋内收-外展角度、最大髋内收-外展角、髋内-收外展的关节变化量及最大膝内收-外展角速度大于足跟着地(P < 0.01)和全足着地者(P < 0.05);前足着地者的踝屈伸最小值大于足跟着地者(P < 0.05),而最大髋内收-外展角速度小于足跟着地者(P < 0.05);③足跟着地和全足着地者的腓骨短肌、腓骨长肌、第三腓骨肌的肌力大于前足着地者(P < 0.05),前足着地者的股中间肌、股外侧肌下束、股外侧肌上束、股内侧肌下束、股内侧肌上束、股内侧肌中束肌力均大于足跟着地(P < 0.01)和全足着地者(P < 0.05);④结果提示:在3-6岁阶段,幼儿多采用足跟或全足着地模式进行奔跑,以满足自己在跑步过程的稳定性,随着年龄的增长,逐渐出现前足着地方式的跑步模式;前足着地能够动用更多髋关节和膝关节额状面的运动来维持人体运动中的稳定,足跟着地和全足着地能够动用更多的小腿前侧和后侧的肌力,而前足着地动用更多的大腿前侧肌力。
ORCID: 0000-0002-8337-3931(赵盼超)
中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程 相似文献
60.